Mesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the Outcome
NCT07379528
·
clinicaltrials.gov ↗
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukaemia (AML)
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia